Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03857646 · ClinicalTrials.gov registry record · Phase 4
The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT03857646 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 66 participants.
The verdict
NCT03857646, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
The goal of this research study is to compare the levels of free fatty acids and free bilirubin between two intravenous lipid emulsion products in premature newborns.
Interventions
- DRUG Intralipid, 20% Intravenous Emulsion
- DRUG Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2019-03-02 |
| Est. Completion | 2020-06-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03857646
The ClinicalTrials.gov registry entry for NCT03857646 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intralipid, 20% Intravenous Emulsion is the first listed.
NCT03857646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03857646 about?
NCT03857646 is a clinical study titled "The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns". The goal of this research study is to compare the levels of free fatty acids and free bilirubin between two intravenous lipid emulsion products in premature newborns.
What is the current status of trial NCT03857646?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2019-03-02. Estimated completion is 2020-06-11.
What interventions are being tested in trial NCT03857646?
The interventions under investigation include: Intralipid, 20% Intravenous Emulsion (DRUG), Soybean oil Medium-chain triglycerides Olive oil Fish Oil (SMOF) lipid (DRUG).
Who is sponsoring clinical trial NCT03857646?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.